GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat

Emanuela Mazzon, Laura Dugo, Jia He Li, Rosanna Di Paola, Tiziana Genovese, Achille P. Caputi, Jie Zhang, Salvatore Cuzzocrea

Research output: Contribution to journalArticle

Abstract

Poly (ADP-ribose) polymerase, a nuclear enzyme activated by DNA strand breaks, has been shown to play an important role in the pathogenesis of inflammatory bowel disease. Here we investigate the effects of 1,11b-dihydro-[2H]benzopyrano [4,3,2-de]isoquinolin-3-one (GPI 6150), a new poly (ADP-ribose) polymerase inhibitor, in animal models of experimental colitis. Colitis was induced in rats by intra-colonic instillation of dinitrobenzene sulfonic acid. Rats experienced hemorrhagic diarrhea and weight loss. At 4 days after administration of dinitrobenzensulfonic acid, the mucosa of the colon exhibited large areas of necrosis. Neutrophil infiltration (determined by histology and an increase in myeloperoxidase activity in the mucosa) was associated with up-regulation of ICAM-1. Immunohistochemistry for poly (ADP-ribose) showed an intense staining in the inflamed colon. GPI 6150 (20 or 40mg/kg daily, i.p.) significantly reduced the degree of hemorrhagic diarrhea and weight loss caused by administration of dinitrobenzensulfonic acid. GPI 6150 also caused a substantial reduction of (i) the degree of colon injury, (ii) the rise in myeloperoxidase activity (mucosa), (iii) the increase in the tissue levels of malondialdehyde, (iv) the increase in staining (immunohistochemistry) for poly (ADP-ribose), as well as (v) the upregulation of ICAM-1 and P-selectin caused by dinitrobenzensulfonic acid in the colon. Thus, GPI 6150 reduces the degree of colitis caused by dinitrobenzensulfonic acid. We propose that GPI 6150 may be useful in the treatment of inflammatory bowel disease.

Original languageEnglish
Pages (from-to)327-337
Number of pages11
JournalBiochemical Pharmacology
Volume64
Issue number2
DOIs
Publication statusPublished - Jul 15 2002

Keywords

  • Bowel disease
  • Free radicals
  • GPI 6150
  • Inflammation
  • Nitric oxide
  • Poly (ADP-ribose) synthethase

ASJC Scopus subject areas

  • Pharmacology

Fingerprint Dive into the research topics of 'GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat'. Together they form a unique fingerprint.

  • Cite this

    Mazzon, E., Dugo, L., Li, J. H., Di Paola, R., Genovese, T., Caputi, A. P., Zhang, J., & Cuzzocrea, S. (2002). GPI 6150, a PARP inhibitor, reduces the colon injury caused by dinitrobenzene sulfonic acid in the rat. Biochemical Pharmacology, 64(2), 327-337. https://doi.org/10.1016/S0006-2952(02)01075-4